Everest Medicines cracks open $451m Hong Kong IPO

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings
Asia

Everest Medicines cracks open $451m Hong Kong IPO

Jonathan Breen
September 25, 2020 08:15 AM
biopharma_stocks_adobe_575x375.jpg

Biopharmaceutical firm Everest Medicines has hit the road for its up to HK$3.5bn ($451m) Hong Kong IPO.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

NomuraCredit SuisseEquity IPOsHealth and BiotechEquityChinaBank of AmericaChina International Capital CorpCitiHong Kong SARAsiaGreater ChinaMorgan StanleyNortheast AsiaAsia PacificEmerging MarketsSRIGoldman Sachs
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article